| Primary |
| Ventricular Tachycardia |
20.3% |
| Torsade De Pointes |
14.5% |
| Disease Recurrence |
11.6% |
| Neuralgia |
8.7% |
| Arrhythmia |
7.2% |
| Cardiac Failure |
7.2% |
| Long Qt Syndrome Congenital |
5.8% |
| Ventricular Extrasystoles |
5.8% |
| Pain |
4.3% |
| Prophylaxis |
4.3% |
| Adverse Event |
2.9% |
| Lung Adenocarcinoma Stage Iv |
2.9% |
| Long Qt Syndrome |
1.4% |
| Myotonia |
1.4% |
| Suicide Attempt |
1.4% |
|
| Drug Ineffective |
17.2% |
| Syncope |
13.8% |
| Skin Exfoliation |
10.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.9% |
| Skin Ulcer |
6.9% |
| Ventricular Fibrillation |
6.9% |
| Dizziness |
3.4% |
| Drug Effect Decreased |
3.4% |
| Dysarthria |
3.4% |
| Leukocytosis |
3.4% |
| Mental Status Changes |
3.4% |
| Myocardial Infarction |
3.4% |
| Rash Generalised |
3.4% |
| Rash Maculo-papular |
3.4% |
| Swelling Face |
3.4% |
| Virus Serology Test Positive |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
13.7% |
| Drug Use For Unknown Indication |
13.0% |
| Ventricular Tachycardia |
12.2% |
| Arrhythmia |
8.4% |
| Pain |
6.9% |
| Cancer Pain |
4.6% |
| Ventricular Extrasystoles |
4.6% |
| Gastritis |
3.8% |
| Anxiety Disorder |
3.1% |
| Back Pain |
3.1% |
| Constipation |
3.1% |
| Disease Recurrence |
3.1% |
| Neuralgia |
3.1% |
| Tachycardia |
3.1% |
| Torsade De Pointes |
3.1% |
| Cerebral Infarction |
2.3% |
| Cytomegalovirus Infection |
2.3% |
| General Anaesthesia |
2.3% |
| Hypothyroidism |
2.3% |
| Nausea |
2.3% |
|
| Ventricular Tachycardia |
11.4% |
| Drug Ineffective |
8.6% |
| Alopecia Totalis |
5.7% |
| Drug Eruption |
5.7% |
| Neutrophil Count Decreased |
5.7% |
| Pneumonia |
5.7% |
| Pyrexia |
5.7% |
| Rash |
5.7% |
| Rash Maculo-papular |
5.7% |
| Skin Exfoliation |
5.7% |
| Syncope |
5.7% |
| White Blood Cell Count Increased |
5.7% |
| Blood Creatinine Increased |
2.9% |
| Dysarthria |
2.9% |
| Erythema |
2.9% |
| Erythema Multiforme |
2.9% |
| Extrasystoles |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Hodgkin's Disease |
2.9% |
| Liver Injury |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.4% |
| Product Used For Unknown Indication |
31.1% |
| Hiv Infection |
3.4% |
| Hypertension |
2.8% |
| Pain |
2.8% |
| Prophylaxis |
2.7% |
| Behcet's Syndrome |
2.6% |
| Pulmonary Arterial Hypertension |
2.6% |
| Arrhythmia |
2.4% |
| Ventricular Tachycardia |
2.3% |
| Nuclear Magnetic Resonance Imaging |
2.1% |
| Hypokalaemia |
2.0% |
| Acute Promyelocytic Leukaemia |
1.9% |
| Multiple Myeloma |
1.6% |
| Cardiac Failure |
1.5% |
| Depression |
1.4% |
| Rheumatoid Arthritis |
1.0% |
| Insomnia |
0.9% |
| Dialysis |
0.8% |
| Nausea |
0.8% |
|
| Vomiting |
11.1% |
| Ventricular Tachycardia |
10.3% |
| Nausea |
7.7% |
| White Blood Cell Count Increased |
7.7% |
| Therapeutic Agent Toxicity |
6.0% |
| Weight Decreased |
6.0% |
| Drug Effect Decreased |
5.1% |
| Neonatal Respiratory Distress Syndrome |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Wound Infection |
4.3% |
| Altered State Of Consciousness |
3.4% |
| Anaemia |
3.4% |
| Death |
3.4% |
| Leukopenia |
3.4% |
| Pneumonia |
3.4% |
| Pyrexia |
3.4% |
| Ventricular Extrasystoles |
3.4% |
| Atrial Flutter |
2.6% |
| Conversion Disorder |
2.6% |
| Drug Eruption |
2.6% |
|
